Skip to main content
Fig. 3 | BMC Women's Health

Fig. 3

From: Efficacy and safety of vaginal suppositories containing combination of Natamycin and Lactulose in treatment of vulvovaginal candidiasis: international, randomized, controlled, superiority clinical trial (combination of Natamycin and Lactulose for treatment of vulvovaginal candidiasis)

Fig. 3

The number and proportion of patients with microscopic recovery at Visit 2. The horizontal axis shows the number of patients with microscopic recovery in each group (Lactulose group, Natamycin + Lactulose group and Pimafucin group), the vertical axis shows the proportion (%) of patients

Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us